Akebia Therapeutics
AKBA
AKBA
166 hedge funds and large institutions have $448M invested in Akebia Therapeutics in 2018 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 73 increasing their positions, 24 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
24% more capital invested
Capital invested by funds: $360M → $448M (+$87.9M)
1.62% less ownership
Funds ownership: 71.53% → 69.91% (-1.6%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
166
Holding in Top 10
1
Calls
$4.16M
Puts
$1.31M
Top Buyers
| 1 | +$135M | |
| 2 | +$25.1M | |
| 3 | +$16.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$6.53M |
Top Sellers
| 1 | -$15.7M | |
| 2 | -$4.72M | |
| 3 | -$4.02M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$3.08M |
| 5 |
First Manhattan
New York
|
-$2.99M |